Logo image of CJR-B.CA

CORUS ENTERTAINMENT INC-B SH (CJR-B.CA) Stock Fundamental Analysis

TSX:CJR-B - Toronto Stock Exchange - CA2208741017 - Common Stock - Currency: CAD

0.095  +0.01 (+11.76%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CJR-B. CJR-B was compared to 12 industry peers in the Media industry. There are concerns on the financial health of CJR-B while its profitability can be described as average. CJR-B does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

CJR-B had negative earnings in the past year.
In the past year CJR-B had a positive cash flow from operations.
CJR-B had negative earnings in 4 of the past 5 years.
CJR-B had a positive operating cash flow in each of the past 5 years.
CJR-B.CA Yearly Net Income VS EBIT VS OCF VS FCFCJR-B.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M

1.2 Ratios

With a Return On Assets value of -51.23%, CJR-B is not doing good in the industry: 63.64% of the companies in the same industry are doing better.
CJR-B's Return On Invested Capital of 9.71% is amongst the best of the industry. CJR-B outperforms 100.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CJR-B is in line with the industry average of 7.62%.
The 3 year average ROIC (8.40%) for CJR-B is below the current ROIC(9.71%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -51.23%
ROE N/A
ROIC 9.71%
ROA(3y)-24.86%
ROA(5y)-17.17%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)8.4%
ROIC(5y)7.93%
CJR-B.CA Yearly ROA, ROE, ROICCJR-B.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100

1.3 Margins

Looking at the Operating Margin, with a value of 11.10%, CJR-B belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
CJR-B's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 56.52%, CJR-B belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
CJR-B's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 11.1%
PM (TTM) N/A
GM 56.52%
OM growth 3Y-17.74%
OM growth 5Y-11.35%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.57%
GM growth 5Y-2.57%
CJR-B.CA Yearly Profit, Operating, Gross MarginsCJR-B.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CJR-B is creating value.
The number of shares outstanding for CJR-B remains at a similar level compared to 1 year ago.
CJR-B has less shares outstanding than it did 5 years ago.
CJR-B has a worse debt/assets ratio than last year.
CJR-B.CA Yearly Shares OutstandingCJR-B.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CJR-B.CA Yearly Total Debt VS Total AssetsCJR-B.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of -1.50, we must say that CJR-B is in the distress zone and has some risk of bankruptcy.
CJR-B has a Altman-Z score (-1.50) which is comparable to the rest of the industry.
CJR-B has a debt to FCF ratio of 15.36. This is a negative value and a sign of low solvency as CJR-B would need 15.36 years to pay back of all of its debts.
The Debt to FCF ratio of CJR-B (15.36) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 15.36
Altman-Z -1.5
ROIC/WACC2.35
WACC4.13%
CJR-B.CA Yearly LT Debt VS Equity VS FCFCJR-B.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 0.80 indicates that CJR-B may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.80, CJR-B is doing worse than 63.64% of the companies in the same industry.
CJR-B has a Quick Ratio of 0.80. This is a bad value and indicates that CJR-B is not financially healthy enough and could expect problems in meeting its short term obligations.
CJR-B has a worse Quick ratio (0.80) than 63.64% of its industry peers.
Industry RankSector Rank
Current Ratio 0.8
Quick Ratio 0.8
CJR-B.CA Yearly Current Assets VS Current LiabilitesCJR-B.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2

3. Growth

3.1 Past

The earnings per share for CJR-B have decreased strongly by -105.56% in the last year.
CJR-B shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -43.12% yearly.
CJR-B shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -15.32%.
Measured over the past years, CJR-B shows a decrease in Revenue. The Revenue has been decreasing by -5.52% on average per year.
EPS 1Y (TTM)-105.56%
EPS 3Y-61.41%
EPS 5Y-43.12%
EPS Q2Q%-30%
Revenue 1Y (TTM)-15.32%
Revenue growth 3Y-6.28%
Revenue growth 5Y-5.52%
Sales Q2Q%-11.55%

3.2 Future

CJR-B is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.12% yearly.
CJR-B is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -5.14% yearly.
EPS Next Y-257.94%
EPS Next 2Y-124.08%
EPS Next 3Y18.12%
EPS Next 5YN/A
Revenue Next Year-11.02%
Revenue Next 2Y-8.02%
Revenue Next 3Y-5.14%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CJR-B.CA Yearly Revenue VS EstimatesCJR-B.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
CJR-B.CA Yearly EPS VS EstimatesCJR-B.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 1 1.5

3

4. Valuation

4.1 Price/Earnings Ratio

CJR-B reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year CJR-B is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CJR-B.CA Price Earnings VS Forward Price EarningsCJR-B.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

90.91% of the companies in the same industry are more expensive than CJR-B, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, CJR-B is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 0.27
EV/EBITDA 1.37
CJR-B.CA Per share dataCJR-B.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 -6

4.3 Compensation for Growth

A more expensive valuation may be justified as CJR-B's earnings are expected to grow with 18.12% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-124.08%
EPS Next 3Y18.12%

0

5. Dividend

5.1 Amount

CJR-B does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CORUS ENTERTAINMENT INC-B SH

TSX:CJR-B (3/7/2025, 7:00:00 PM)

0.095

+0.01 (+11.76%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)01-10 2025-01-10/bmo
Earnings (Next)04-04 2025-04-04
Inst Owners4.14%
Inst Owner ChangeN/A
Ins Owners3.57%
Ins Owner ChangeN/A
Market Cap18.63M
Analysts43.08
Price Target0.09 (-5.26%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)52.35%
Min EPS beat(2)33.26%
Max EPS beat(2)71.44%
EPS beat(4)2
Avg EPS beat(4)-39.05%
Min EPS beat(4)-251.7%
Max EPS beat(4)71.44%
EPS beat(8)5
Avg EPS beat(8)-1%
EPS beat(12)5
Avg EPS beat(12)-165.39%
EPS beat(16)9
Avg EPS beat(16)-120.37%
Revenue beat(2)0
Avg Revenue beat(2)-5.73%
Min Revenue beat(2)-7.81%
Max Revenue beat(2)-3.66%
Revenue beat(4)0
Avg Revenue beat(4)-5.71%
Min Revenue beat(4)-7.81%
Max Revenue beat(4)-3.66%
Revenue beat(8)0
Avg Revenue beat(8)-4.37%
Revenue beat(12)1
Avg Revenue beat(12)-3.76%
Revenue beat(16)1
Avg Revenue beat(16)-3.22%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-132%
EPS NY rev (1m)0%
EPS NY rev (3m)-78.88%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.2%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.43%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.02
P/FCF 0.27
P/OCF 0.21
P/B N/A
P/tB N/A
EV/EBITDA 1.37
EPS(TTM)-0.01
EYN/A
EPS(NY)-0.15
Fwd EYN/A
FCF(TTM)0.36
FCFY377.26%
OCF(TTM)0.45
OCFY477.14%
SpS6.26
BVpS-2.3
TBVpS-6.31
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -51.23%
ROE N/A
ROCE 13.48%
ROIC 9.71%
ROICexc 10.63%
ROICexgc 71.12%
OM 11.1%
PM (TTM) N/A
GM 56.52%
FCFM 5.72%
ROA(3y)-24.86%
ROA(5y)-17.17%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)8.4%
ROIC(5y)7.93%
ROICexc(3y)8.88%
ROICexc(5y)8.26%
ROICexgc(3y)101.91%
ROICexgc(5y)97.84%
ROCE(3y)11.67%
ROCE(5y)11.02%
ROICexcg growth 3Y19.08%
ROICexcg growth 5Y5.54%
ROICexc growth 3Y19.25%
ROICexc growth 5Y13.77%
OM growth 3Y-17.74%
OM growth 5Y-11.35%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.57%
GM growth 5Y-2.57%
F-Score5
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 15.36
Debt/EBITDA 1.46
Cap/Depr 3.1%
Cap/Sales 1.52%
Interest Coverage 2.07
Cash Conversion 12.07%
Profit Quality N/A
Current Ratio 0.8
Quick Ratio 0.8
Altman-Z -1.5
F-Score5
WACC4.13%
ROIC/WACC2.35
Cap/Depr(3y)2.34%
Cap/Depr(5y)2.46%
Cap/Sales(3y)1.13%
Cap/Sales(5y)1.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-105.56%
EPS 3Y-61.41%
EPS 5Y-43.12%
EPS Q2Q%-30%
EPS Next Y-257.94%
EPS Next 2Y-124.08%
EPS Next 3Y18.12%
EPS Next 5YN/A
Revenue 1Y (TTM)-15.32%
Revenue growth 3Y-6.28%
Revenue growth 5Y-5.52%
Sales Q2Q%-11.55%
Revenue Next Year-11.02%
Revenue Next 2Y-8.02%
Revenue Next 3Y-5.14%
Revenue Next 5YN/A
EBIT growth 1Y-25.27%
EBIT growth 3Y-22.91%
EBIT growth 5Y-16.24%
EBIT Next Year21.15%
EBIT Next 3Y11.2%
EBIT Next 5YN/A
FCF growth 1Y-61.78%
FCF growth 3Y-23.78%
FCF growth 5Y-18.48%
OCF growth 1Y-56.16%
OCF growth 3Y-21.92%
OCF growth 5Y-17.58%